How effective is it to switch among atypical antipsychotics? A randomized, open-label study of algorithm-based antipsychotic treatment to symptomatic patients with schizophrenia in a real-world clinical setting

被引：0
|
作者：
Suzuki, T.
Uchida, H.
Watanabe, K.
Tanabe, A.
Tsunoda, K.
Nomura, K.
Niou, S.
Takeuchi, H.
Yagi, G.
Kashima, H.
机构：
[1] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[2] Inokashira Hosp, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 44 条
  • [21] Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study
    Zhang, Y. L.
    Zhou, C.
    Li, X. F.
    Yang, M. N.
    Tao, L.
    Zheng, X. Y.
    Jia, Y. S.
    OBESITY SCIENCE & PRACTICE, 2019, 5 (04): : 366 - 375
  • [22] COPD PATIENTS RECEIVING FIXED OR OPEN-LABEL TRIPLE THERAPY: INITIATION AND PERSISTENCE OF TREATMENT BASED ON DATA FROM A REAL-WORLD AMBULATORY MEDICALIZED DATABASE IN FRANCE
    Deslee, G.
    Fabry-Vendrand, C.
    Poccardi, N.
    Thabut, G.
    Eteve-Pitsaer, C.
    Coriat, A.
    Pinto, T.
    VALUE IN HEALTH, 2022, 25 (12) : S281 - S282
  • [23] A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
    David H Adams
    Bruce J Kinon
    Simin Baygani
    Brian A Millen
    Isabella Velona
    Sara Kollack-Walker
    David P Walling
    BMC Psychiatry, 13
  • [24] A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
    Adams, David H.
    Kinon, Bruce J.
    Baygani, Simin
    Millen, Brian A.
    Velona, Isabella
    Kollack-Walker, Sara
    Walling, David P.
    BMC PSYCHIATRY, 2013, 13
  • [25] Opioid-Free Recovery After Hernia Repair with HTX-011 as the Foundation of a Non-Opioid, Multimodal Analgesia Regimen in a Real-World Setting: A Randomized, Open-Label Study
    Harold Minkowitz
    Roy Soto
    John Fanikos
    Gregory B. Hammer
    Neel Mehta
    Jia Hu
    Jay Redan
    Pain and Therapy, 2021, 10 : 1295 - 1308
  • [26] Opioid-Free Recovery After Hernia Repair with HTX-011 as the Foundation of a Non-Opioid, Multimodal Analgesia Regimen in a Real-World Setting: A Randomized, Open-Label Study
    Minkowitz, Harold
    Soto, Roy
    Fanikos, John
    Hammer, Gregory B.
    Mehta, Neel
    Hu, Jia
    Redan, Jay
    PAIN AND THERAPY, 2021, 10 (02) : 1295 - 1308
  • [27] Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting A Randomized, Open-Label Study
    Ekesbo, Rickard
    Sjostedt, Svante
    Sorngard, Helene
    CLINICAL DRUG INVESTIGATION, 2011, 31 (03) : 181 - 189
  • [28] Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting
    Di Lorenzo, Rosaria
    Ferri, Paola
    Cameli, Michela
    Rovesti, Sergio
    Piemonte, Chiara
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 183 - 198
  • [29] Effectiveness of delayed-release dimethyl fumarate on clinical disease activity and patient-reported outcomes in patients with relapsing-remitting multiple sclerosis in the real-world setting: a multicentre, open-label study (PROTEC)
    Berger, T.
    Brochet, B.
    Confalonieri, P.
    Giacomini, P. S.
    Montalban, X.
    Vasco Salgado, A.
    Okwuokenye, M.
    Marantz, J. L.
    Mair, W.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 298 - 299
  • [30] A randomized, open-label, multicentre, phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy based treatment strategy in patients with hormone receptor positive/HER2-negative metastatic breast cancer in a real world setting
    Loibl, Sibylle
    Barinoff, Jana
    Seiler, Sabine
    Decker, Thomas
    Denkert, Carsten
    Luebbe, Kristina
    Furlanetto, Jenny
    Mueller, Volkmar
    Mundhenke, Christoph
    Schmidt, Marcus
    Von Minckwitz, Gunter
    Uhlig, Mathias
    Burchardi, Nicole
    Thill, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345